GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
2,593.90
-73.05 (-2.74%)
At close: Feb 13, 2026

BOM:500660 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
439,422487,432329,173224,319281,714244,012
Market Cap Growth
25.74%48.08%46.74%-20.37%15.45%15.67%
Enterprise Value
419,170466,472313,334211,499270,099237,483
Last Close Price
2593.902840.331885.831256.531486.111262.72
PE Ratio
43.0452.5555.8036.7316.6268.13
Forward PE
38.8049.8844.1635.5842.3040.93
PS Ratio
11.5613.009.536.908.598.34
PB Ratio
25.7324.9818.5212.8810.5816.51
P/TBV Ratio
25.8625.1518.7713.1410.7217.01
P/FCF Ratio
-38.4859.7650.9636.3045.72
P/OCF Ratio
-37.7956.5646.3334.7542.22
PEG Ratio
-6.496.491.442.172.82
EV/Sales Ratio
11.0312.449.076.508.248.12
EV/EBITDA Ratio
32.7140.4735.5826.8336.3641.42
EV/EBIT Ratio
34.1641.8637.3528.2638.6545.71
EV/FCF Ratio
-36.8256.8948.0534.8044.50
Debt / Equity Ratio
0.020.010.010.010.010.02
Debt / EBITDA Ratio
0.030.010.020.020.030.06
Debt / FCF Ratio
-0.010.030.040.030.07
Net Debt / Equity Ratio
-1.19-1.27-1.03-0.94-1.06-0.75
Net Debt / EBITDA Ratio
-1.60-2.16-2.09-2.08-3.78-1.92
Net Debt / FCF Ratio
--1.96-3.34-3.72-3.62-2.07
Asset Turnover
-0.981.000.820.850.94
Inventory Turnover
-2.812.752.622.552.49
Quick Ratio
-1.501.451.501.831.02
Current Ratio
-1.791.841.882.181.63
Return on Equity (ROE)
-49.75%33.53%27.59%18.39%17.42%
Return on Assets (ROA)
-18.17%15.24%11.75%11.28%10.39%
Return on Invested Capital (ROIC)
--2875.95%-299.81%55.90%
Return on Capital Employed (ROCE)
-50.60%41.30%37.40%23.80%29.50%
Earnings Yield
2.32%1.90%1.79%2.72%6.02%1.47%
FCF Yield
-2.60%1.67%1.96%2.76%2.19%
Dividend Yield
1.57%1.48%1.70%2.55%2.02%2.38%
Payout Ratio
-80.79%91.80%249.80%29.89%189.04%
Total Shareholder Return
1.56%1.48%1.70%2.55%2.02%2.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.